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The social embedding of biomedicine: an analysis
of German media debates 1995–2004
Peter Weingart, Christian Salzmann and Stefan Wörmann
Biomedical research and technologies such as cloning, stem cell research, and
the deciphering of the human genome have met with opposition—albeit of dif-
ferent intensity—motivated by ethical values. The debates over the continua-
tion of research and the implementation of the respective technologies are
being staged in the mass media. The media have assumed the function of
“embedding” controversial knowledge and technologies into society by using
public discourse. The hypothesis is that these discourses follow a common pat-
tern revealing the process of “embedding,” and ultimately leading to a change
of existing values. In this study, three debates over cloning, stem cell research
and the Human Genome Project are analyzed in ten German daily and weekly
newspapers over the period 1995–2004. It is shown that the patterns of report-
ing are more complex than anticipated. Rather than being identical for all tech-
nologies, they reveal different courses depending on the kind of knowledge/
technology and value sensitivity.
Keywords: biomedicine, science and technology studies, media analysis, cloning,
stem cell research, human genome project, social embedding.
1. The “embedding” of new knowledge and technologies through media debates
The public debates over new advances in biomedicine and options of their implementation
reflect the complex process of “embedding” new knowledge and technologies in society. In
particular cases where these options involve deep-seated values and ethical convictions—such
as the dignity of the human embryo—these public debates are crucial for the success of the
process of “embedding.” By “embedding” we mean the process of the introduction of new
knowledge and technologies and their subsequent adaptation to opposing values. The adapta-
tion is mutual as both, technologies and values, change in the process. At the beginning of the
process claims of scientists meet with both fears and enthusiasm on the part of the public
expressed in the media. The crucial phase of the process, we believe, is the debate that is car-
ried out to bring the often utopian visions and optimistic propaganda of the scientists in line
with the fears and objections of the public as it is represented in and actively staged by the
media. Only when that debate is more or less closed can one speak of a “normalization.” The
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objective of our analysis, the results of which are to be reported below, was to identify the dis-
cursive mechanisms and argumentative resources which are employed when new knowledge
and technology clash with societal values. We started with the hypothesis that in such cases
debates follow a certain pattern: a first phase is characterized by far-reaching promises, even
utopian visions of the implications of new research lines. These are met with value-bound
resistance. The more utopian the promises, the more dystopian are the arguments in opposi-
tion to the new knowledge or technology. In a second phase of the debate, this value-bound
resistance is gradually overcome as concrete research results are linked to individuals’ inter-
ests. As we look here at three debates over biomedical knowledge, these interests pertain
above all to health. Thus, strongly held general values such as the inviolateness of human
nature are only upheld “as the moral barriers that they represent are technical barriers at the
same time. Under the impact of new technologies the existing moral becomes outdated” (Van
den Daele, 1985: 205). This process is complicated by the fact that we are dealing with dif-
ferent “morals” but also with different technologies (Van den Daele, 2000). Thus, the out-
come may differ in the extent both to which values have changed and to which technologies
have been adapted. The objective is to look at the patterns of interaction between scientific–
technical innovation and existing values proper.
In mass democracies, this process takes place in public debates staged by and in the
media. Here, the media have the function of a forum, reflecting broad public opinion as well
as organizing it. They are the public arena in which social, ethical and legal aspects of the
implementation of new technologies are debated (Neidhardt, 1993). Being independent enti-
ties the media operate according to their own criteria of relevance (Staab, 1990; Eilders,
1997). At the same time, they play a key role in legitimating political decisions, in particular
by staging debates, i.e. the presentation of different positions and the provision of arguments
(Gerhards et al., 1998). The legitimating function of the media is not restricted to politics but
extends to science and technology as well. Value related resistance to certain research lines
can undermine their legal and financial base and prevent further development (Gregory and
Miller, 1998).
Given the centrality of the mass media in modern pluralist societies for staging public
debates on controversial topics, such debates become an object of interest as an important
mechanism of “embedding” new knowledge1 into society. A whole series of studies has
focused on the Human Genome Project (HGP), on “Dolly” and cloning as well as on other
biomedical techniques. Even though they address different questions and proceed with dif-
ferent methodologies, many of their findings are relevant to our own. This is true even
though these studies have been carried out in countries other than Germany. Some show very
similar patterns, others reveal differences that can be explained with different values, legal
conditions (cf. in the case of stem cell research) and political conditions. Nerlich et al.
(2002) in their analysis of how the completion of the HGP was communicated to the public
demonstrate the importance of value contexts and how scientists and policymakers play to
them by using appropriate metaphors. However, similar patterns emerge with respect to the
overall arguments either opposing or favoring the new technique: the “spectre of designer
babies,” although not explicitly mentioned in their material of British newspapers, “loomed
large in the mid-market tabloid coverage,” confronted by a “generally positive medical mes-
sage” of curing major diseases and increasing life expectancy (Nerlich et al., 2002: 462).
Analysis of reactions in the US (consumer telephone survey and media analysis) shows a
very similar ambivalence to the new knowledge and sees it reflecting the same division into
a “Discourse of Great Promise” and a “Discourse of Concern” that Durant, Hansen and
Bauer had already observed in early focus groups (Tambor et al., 2002: 35; Durant et al.,
1996). Human cloning, even though not mentioned in the press in connection with the HGP,
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was nonetheless on the minds of respondents. According to the authors, this supports a
remark by Francis Collins, head of the HGP, that people tend to “lump anything with ‘gen’
as the human genome project—gene therapy, GM foods, cloning—it’s all the same thing”
(cited in Tambor et al., 2002: 36).
The debate on cloning is still more sensitive, the fears associated with cloning reach
deep, and they are connected to “mistrust in scientific endeavor, in the motives of scientists,
and in existing systems of regulation and legislation” (Petersen, 2002: 73). Scientists empha-
size the medical benefits of cloning, too, and the media frequently report about their opti-
mistic views but especially in the case of cloning the climate of positive opinion is hard to
sustain. After the announcement of Dolly, reporting in Australian papers, for instance, high-
lighted the dangers of human cloning and the need to regulate cloning research. “Stories
‘framed’ the issue largely in terms of risk and imminent threat” (Petersen, 2002: 85). The
activities of pseudo-scientists such as Richard Seed and Brigitte Boiselier of the Raelian sect
that claimed to have achieved or were just about to clone human babies and similar
announcements of the credentialed American fertility experts Zavos and Antinori con-
tributed to a cloning hype throughout 2001 that raised already existing anxieties to even
higher levels (Nerlich and Clarke, 2003). All of these media events reveal both commonali-
ties and differences. They are, furthermore, all examples of what we refer to as processes of
“embedding” of new knowledge. The objective is to identify the patterns and mechanisms
that create them.
Research into discourses on such diverse issues as nuclear energy (Gamson and
Modigliani, 1989), abortion (Gerhards et al., 1998), the legalization of drugs (Weßler, 1999),
and climate change (Weingart et al., 2002) allows a number of conclusions about the dynam-
ics of such discourses.
● The issue in such discourses is not finding the better argument. Rather the discourse
evolves under the operative conditions of the mass media.
● Arguments and their value references appear only in “bits and pieces” (Weßler, 1999:
70). Owing to permanent references to previous arguments, fragmentary statements can
only be analyzed in the context of larger text corpora (Entman, 1993).
● In the case of subjects that present dilemmas, the discourse tends to become moralizing
which makes the legitimation of (political) decisions more difficult.
● In any discourse, “fragmented bits of understanding reality” (Hajer, 1993: 41) come together
and different arguments and positions may coalesce to a cluster which subsequently
becomes the reference for all further arguments. These clusters assume the function of a sto-
ryline for a group of actors, together with adjoining problem definitions, attributions of
causes and problem solutions. If there is discursive closure such a storyline can dominate so
much that it is binding for the participants in the discourse (Weingart et al., 2002).
● Owing to the limited attention of the media and their audiences, symbols, metaphors and
keywords, i.e. abbreviated representations of more complex interpretive patterns, have an
important function.
● Only few communicated events provoke sufficient reactions from actors that, in turn,
trigger counter reactions so that, for example, a “climate change discourse” evolves that
remains stable over some time and serves as a news value for the media.
During the first half of the 1990s the leading German media paid increased attention to the
topic of biomedicine (Kohring et al., 1999; Hampel et al., 1998).2 With the deciphering of the
human genome the volume of reporting in the media has increased even further. Not only are
the medical and scientific implications (i.e. potential forms of therapy) being discussed but so
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also are the social, ethical and legal aspects linked to them. Thus, in the case of stem cell
research the issue of human dignity is discussed together with the issue of the freedom of
research or the right to health.3 The debate on embryonic stem cell research is carried out in
the newspapers, above all the Frankfurter Allgemeine Zeitung (FAZ) with such intensity that
the former president of the Max Planck Society was suspicious of a synchronized bioethical
campaign of German daily newspapers (Markl, 2001).
Although this study focuses on the media debates only and leaves the political context
aside, one remark is warranted. The intensity with which the debate on stem cell research was
carried out in Germany is often explained with that country’s particular sensitivity about its
past. Indeed, recent developments of biomedical techniques clearly raise the specter of eugen-
ics. A 1991 exhibition, not in Germany but in Paris, made the point already: “Today, astound-
ing paradox, the generation following Nazism is giving the world the tools of eugenics
beyond the wildest Hitlerian dreams” (M. Vaquin, cited in Kevles, 2000: 180). Albeit, at least
to our knowledge not established by systematic empirical data but based on impressionistic
perception of media coverage, it is highly probable that references to Nazi crimes in connec-
tion with eugenics are more frequent here than in the Anglo-Saxon countries and contribute
to a heightened level of alarm in the German public with respect to potential abuses of bio-
medical techniques such as the use of embryos in stem cell research or cloning.
The multilayered quality of the debate is due to the fact that biomedicine cuts across a
whole series of applications (Dolata, 1998: 144). This is exemplified in the area of molecular
medicine. Embryos that are produced in artificial insemination and are not transferred into the
uterus may be used as a basis for the production of human embryonic stem cells. The tech-
nique of artificial insemination is also a condition for preimplantation diagnosis (PID) which
was clinically implemented successfully for the first time in 1990 (Handyside et al., 1990).
The discussion about PID and other genetic tests is tightly linked to progress in the Human
Genome Project which, in turn, is the basis for the discovery of genes causing diseases. In the
discussion about stem cell research one finds references to the possibilities of therapeutic
cloning, and since 1997 reproductive cloning—in the cloned sheep “Dolly”—is an important
referent in the public debate on genetic engineering because it signals the possibility of the
cloning of humans (Mieth, 1998; Kollek, 1998).
The debate on the different strands of biomedical research and technology has been until
very recently the dominating public debate related to science and may therefore be taken as
a paramount example of the “embedding” of new knowledge into society.
2. Scope and methodology of the study
The empirical base of the study is the reporting on biomedicine in ten daily and weekly
German newspapers over the period between 1995 and 2004.4 A quantitative analysis is based
on a set of 26 keywords and clusters of keywords that could be searched electronically. With
these data we have comprehensive information about media attention to biomedicine over the
entire period and not just about the debates surrounding it.
A second part of the quantitative analysis differentiates the material on biomedicine and
focuses on three debates: the cloned sheep “Dolly” (1997: 199 articles),5 the Human Genome
Project (2000: 360 articles), and stem cell research6 (2001–2: 931 articles). Debates are com-
munications that last for a certain time, are carried out in several media, and comprise a certain
number of articles dealing with the same issue. Again, the curves gained from the number of
articles on the respective issue that appeared day by day indicate the level of attention. They can
be linked to specific events that explain particular peaks. The overall shape of the curves reveals
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the course of “issue attention” over the duration of the entire debate. They were coded accord-
ing to source, author, origin of author, date, title, section, topic and subtopic, and occasion.7
The qualitative content analysis (Mayring, 2000) focuses on a more detailed look at the
debates. The reconstruction of the debates requires a differential weighting of articles. While
mere reports are included, opinion pieces such as commentaries and lead articles are deemed
more important. The chronological analysis of these articles serves to trace the course of the
debate as well as the arguments and positions of diverse actors. The analysis is strictly
chronological, done by two coders separately. Typical quotes were identified by both, then
interpreted and followed by a subsequent analysis. The qualitative analysis was oriented by
the following guiding questions:
● Which event triggers the reporting?
● Which actors are speaking?
● What share of the article is being taken by comments and what is their tenor?
● What are the central issues of conflict in the debate?
● What are the respective arguments on the “pro-” and “contra-” sides?
● Where is the boundary between the technically possible and the politically and ethically
acceptable being drawn?
The methodology thus combines quantitative and qualitative content analysis. The thesis is
that debates share a common pattern: the beginning of a debate is characterized by a general,
ethically based resistance to the new knowledge/technology in question. Subsequently the
conflict between ethical values and the new knowledge/technology is gradually resolved by
referring it to detailed problems such as concrete forms of implementation. The ethical resis-
tance is gradually overcome by appeals to piecemeal applications. The technology is not
being rejected but, instead, the values are adapted to it.
3. Results
Quantitative analysis
A first overview shows that media attention for biomedicine has grown dramatically around
the year 2000. Based on the occurrence of four keywords—biomedicine, stem cells, cloning,
and Human Genome Project (with respective truncations)8—the curves show the increase of
attention around 2000 (and the subsequent decrease) (Figure 1). The differences are also
instructive. Stem cells and cloning attract most attention.
Cloning is a special case, however. It attracted media attention since the announcement
of Dolly’s birth in 1997.9 But since then the metaphorical use of the term “cloning” has
increased, i.e. it has been used in many other contexts which explains why it appears in many
non-technical articles.
It is also notable that the intensity of media reporting is and remains higher in the case
of stem cells and cloning than for the Human Genome Project. Generally, the news value of
biomedicine has increased so that relatively small events have a higher probability of being
reported.
In order to find debates, we looked at the frequency curve for five keywords—stem cell,
cloning, bioethics, National Ethics Council (Nationaler Ethikrat, NER), and PID—in two-
week intervals. Thus, peaks could be identified in clearly demarcated time spans.10 These are
taken to be debates. However, the frequency curves are only representations of the media
career of a concept. The ultimate identification of a debate can only be achieved by analyzing
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concrete articles. Three debates were thus identified: cloned sheep “Dolly” (24 February–12
June 1997),11 the cracking of the human genome (3 April–31 December 2000),12 and stem cell
research (1998–2002 with the emphasis on the period 2001–2).13 Obviously, the operational
definition of a debate does not cover the actual extension of the debates on each of the three
topics but is limited to the time period for which the intensified media reporting could be
observed. Debates over cloning reach back at least to the late 1970s when the perspective of
cloning moved closer by the advances of molecular biology triggering fictitious reports of the
successful cloning of humans (Rorvik, 1978). The same is true for the Human Genome Project
albeit not in that particular form. But visions of the identification of specific genes and their
functions date back to Mendel’s discovery of heredity although the obstacles seemed insur-
mountable. Resistance to applications of respective techniques has been provided by many
authors even before their concrete availability (e.g. Etzioni, 1973). These precursors to the
much more recent debates reflected in our media coverage will go unmentioned in this analy-
sis even though some aspects of the pattern we are looking for—such as the initial utopian
promises and dystopian opposition—may actually have taken place then. This must be kept in
mind when interpreting the patterns of the attention cycles presented below.
The quantitative data about the three debates show quite different patterns. The “cloning
debate” follows the somewhat expected course (Figure 2). The initial peak reflecting the pre-
sentation to the press of “Dolly,” the cloned sheep, is followed by a series of ever smaller
peaks related to different political events, the first of which is a unanimous vote by the
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Figure 1. Media attention to biomedicine 1995–2004.
German parliament, the Bundestag, banning the cloning of humans. With this the debate is
practically over as the consensus against cloning is nearly complete. A closer look shows that
a few voices wanted to keep open the option of therapeutic cloning which may signal a future
revival of the debate and the embedding of cloning on the health ticket.
The “human genome project” debate reveals a quite different pattern (Figure 3). One peak at
the beginning in April 2000 was triggered by Craig Venter’s press announcement that he had
already cracked the code. This attracted media attention not because the technology raised
moral opposition but because the competition between publicly funded and private research
was at issue. The second and only other significant peak in June 2000 was caused by the press
conference of Bill Clinton and Tony Blair where the two statesmen declared all data from the
project to be made publicly accessible. If there was an ethical issue, it pertained to the opposi-
tion against the commercialization of the human genome data, i.e. a regulatory issue.
The debate over “stem cell research” shows yet another pattern (Figure 4). Triggered by
the declaration of the German science funding agency (DFG) that it wanted to import stem
cells, the subsequent debate is characterized by a series of peaks that indicates a relatively
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Figure 2. Debate over cloning.
high level of media attention over the entire length of the debate. It ends with the decision of
the German Bundestag at the end of January 2002 to ban the production of new cell lines and
to allow research with imported cell lines only. This shows that the entire debate was closely
linked to that particular decision and depended on its outcome.
Qualitative analysis
The debates were then analyzed according to the guiding questions (cf. above) in order to
identify common patterns and differences.
Cloning On 23 February 1997, the British scientist Ian Wilmut announced the first mam-
mal cloned from a differentiated cell. With this innovation the conviction that no new life
could be created from differentiated cells was refuted. Wilmut’s presentation of Dolly ini-
tiated the media debate in 1997. Already the first report in the tabloid Bild made reference
to the cloning of humans which subsequently became the horror scenario around which the
entire debate developed. The cloning debate is special in the sense that the utopian vision
of cloning is actually a dystopia in the eyes of virtually every participant in the debate.
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Figure 3. Debate over the HGP.
Science has moved closer to the dream of the reproduction of life.
A NIGHTMARE! (Bild, 24 February 1997)
The birth of the sheep Dolly is a beacon like the first nuclear explosion. The cloned
human must not be. (Handelsblatt, 27 February 1997, p. 2)
“Now everything is doable”. With the appearance of the cloned sheep “Dolly” a dam
seems broken: Identical copies also of humans will be producible in whatever numbers.
(Der Spiegel, 10/1997 (3 March 1997), p. 216)
Wilmut himself admitted that the possibility of cloning humans had become real and
called for “unequivocal laws” to prevent this (Der Spiegel, 10/1997 (3 March 1997), p.
220). In fact, his achievement opened the door to high-tech eugenics. Thus, one option
would have been that cloning would be launched with a utopian eugenic perspective.
Weingart et al.: Social embedding of biomedicine 389
28
-
AP
R
-2
00
1
05
-M
AY
-
20
01
10
-M
AY
-
20
01
16
-M
AY
-
20
01
22
-M
AY
-
20
01
29
-
M
AY
-
20
01
03
-
JU
N-
20
01
09
-
JU
N-
20
01
16
-J
UN
-2
00
1
22
-J
UN
-2
00
1
28
-
JU
N-
20
01
04
-J
UL
-2
00
1
10
-J
UL
-2
00
1
16
-J
UL
-2
00
1
21
-J
UL
-2
00
1
27
-J
UL
-2
00
1
02
-A
UG
-2
00
1
08
-
AU
G
-2
00
1
14
-A
UG
-2
00
1
21
-A
UG
-2
00
1
28
-
AU
G
-2
00
1
05
-S
EP
-2
00
1
12
-S
EP
-2
00
1
21
-S
EP
-2
00
1
29
-
SE
P-
20
01
12
-O
CT
-
20
01
23
-
O
CT
-
20
01
30
-O
CT
-
20
01
06
-N
OV
-
20
01
12
-N
OV
-
20
01
19
-
N
OV
-
20
01
26
-N
OV
-
20
01
01
-D
EC
-2
00
1
07
-D
EC
-2
00
1
13
-
D
EC
-2
00
1
19
-
D
EC
-2
00
1
31
-D
EC
-2
00
1
08
-
JA
N
-2
00
2
14
-J
AN
-2
00
2
19
-
JA
N
-2
00
2
25
-J
AN
-2
00
2
31
-J
AN
-2
00
2
Date
0
5
10
15
20
25
N
um
be
r o
f a
rt
ic
le
s
 
1 DFG recommendation
2 Clement visits Israel and debate on principles of the German Bundestag about genetic engineering
3 Did the University of Kiel request embryonic stem cells from Australia?
4 Stem cells in Munich and Cologne and suspension of decision on stem cell 
5 no special event 
6 US-decision and statement of President Bush 
7 Embryo cloned by a US-company
8 Statement of the NER
9 Decision of the German Bundestag 
1
2
3
4
5
6
7 8
9
Figure 4. Debate over stem cell research.
Instead, the rejection of cloning humans was unanimous. The common reason was that
cloning conflicts with human dignity and individuality. Fewer are the visions that
cloning would have negative consequences for society if only the good, beautiful and
rich would be cloned. These social dystopias are nearly always linked to the breaking of
a taboo. If this happened, thus the argument, such a development would end with
Huxley’s Brave New World.
The chimera of a terrible creature is loose, as disgusting as Frankenstein’s monster and
as threatening as Godzilla: human clones, we have learned, could be created within two
years. This vision is dreadful for everyone. (FAZ, 11 April 1997, p. 35)
There are very few proponents of the technology, and they do not propagate cloning humans.
Rather they argue against an absolute ban on cloning because it would close the door to thera-
peutic cloning with its many options for curing diseases. This reference to medical applications
of cloning and the journalists’ doubts about the possibility to stabilize an absolute ban over time
already signal in which direction one can expect the embedding of therapeutic cloning to go.
The public reacts to “Dolly” with moral nightmares. All of a sudden the breeding fan-
tasies return that belonged to the literature of the 19th and early 20th centuries: the dou-
ble, the homunculus, machine man—it is as if concern with this freaking zoo had only
been delayed … In Scotland is a sheep. It is supposed to produce proteins, maybe also
milk, meat and wool. But the talk is about humans.
In medicine moral imagination comes into trouble. The fantasies lose part of their threat-
ening nature when the curing or even only the containment of diseases is at issue. (FAZ,
27 February 1997, p. 39)
All false alarm? No one thinks about cloning humans? We should not be appeased
too easily. As so often there could be “appliers” who propagate the doable so long until
we take it to be the desirable—and indispensable to secure the economic position! (SZ,
26 February 1997, p. 4)
The rejection of cloning is accompanied by comments from journalists that the new technique
will ultimately be realized against resistance, be it by mad scientists and/or totalitarian states.
Der Spiegel commented that the ban on cloning humans will not be easily upheld in view of
therapeutic reproductive applications in the case of female infertility, and that researchers had
already prepared the ideological terrain for “man to measure” by postulating the power of the
gene (Der Spiegel, 10/1997 (3 March 1997), p. 222).
Der Spiegel: There is great fear that the technique will be abused.
Wilmut: This fear is completely justified. We have said from the beginning: With
our technique we can produce genetic copies of humans. Only unequivocal
laws can prevent that.
(Der Spiegel, 10/1997 (3 March 1997), p. 220)
A worldwide proscription of the cloning of humans will hardly be reached. There are too
many potential clients who are fascinated by the idea and who would pay substantial
sums for a clone. (SZ, 30 April 1997, p. 4)
“It will not be possible to stop cloning”, declares US-biologist Lee Silver. “Now, everything
is doable, all limitations have collapsed.” (Der Spiegel, 10/1997 (3 March 1997), p. 219)
The question of all questions reads: will legal barriers that are porous anyway hold per-
manently? Will society and its concept of the permissible … not change so much in the
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next one to two decades that, for example, the “law protecting embryos” of 1990 will not
seem “up to date” anymore? (FAZ, 26 February 1997, p. 1)
Human Genome Project The debate over the decoding of the human genome differs from
the others because as a scientific achievement it was hailed more or less unanimously. The
beginning of the debate was not the press conference at which the final success was
announced. Instead it began already in early 2000 with hints from Craig Venter that his
company had decoded 99 percent of the human genome. Subsequently, four issues were dis-
cussed: 1) To what extent is Venter’s assertion credible, and what is the quality of his data? 2)
To what extent may parts of the human genome be patented? 3) What are the implications of
the competition between public and privately funded science? 4) In connection to gene chips
and genetic screening: how is one to deal with knowledge about one’s genes vis-a-vis insur-
ance companies and employers?
At the press conference of 26 June 2000, Bill Clinton and Tony Blair announced the end
of the race between public and private research for the genome and promised future collabo-
ration. Subsequently, the question of how to deal with the new knowledge moved to the fore-
ground. Many authors called for an ethical research that would make it possible to identify
and to react to problems created by this new knowledge as early as possible.
Two aspects were the focus of the debate throughout. Critics of the new knowledge
warned of a new eugenics that would spread in reaction to individual demand. In due course
this would lead to pressure on individuals with a genetic defect who would have to justify
themselves for their condition. At the same time, the danger is cited that knowledge about the
genome will feed the readiness to intervene into the human gene pool.14 This scenario is
regarded as the breach of an ethical barrier and represents the dystopia.
Unfortunately we have prepared an entire generation of children for a new eugenic era
by having indoctrinated them: You are your genes. (Jeremy Rifkin in an interview in SZ,
9 August 2000, p. 15)
For the time being the barrier against cloning of humans and interventions into the germ
line holds—but there are already noisy protests against the latter. (Jens Reich in Die Zeit,
27/2000 (29 June 2000), p. 1)
Once God’s image, now gene-construct … Only extreme control and discipline could prevent
that people would be discriminated because of their genome. (Die Welt, 8 April 2000, p. 10)
Those in favor argue that the new knowledge about the genome will lead to entirely new ther-
apeutic possibilities, above all individualized medications.
We see the day coming that therapies like radiation and chemotherapy with their treacher-
ous side effects and uncertainties will be medical anachronisms. This day will not be tomor-
row or next year. And it cannot be brought about by one person, firm or organization. The
revolution needs more than one soldier. (Craig Venter in FAZ, 8 April 2000, p. 43)
Again, the emphasis is on individual health interests being served by the new knowledge rather
than collective measures that are the core of the dystopian images painted by the critics.
Stem cell research The crucial phase of the debate over stem cell research lasted from
4 May 2001 to 2 February 2002, in spite of the fact that the technology to multiply and cul-
tivate stem cells had been available since the fall of 1998. Before the crucial phase of the
debate began, the media had discussed at a relatively low volume various problems related to
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stem cells. The positive and critical arguments that had been offered during that time did not
change essentially in their structure in the crucial phase starting May 2001. This phase was
initiated by a declaration of the German Science Foundation (DFG) calling upon legislators
to “allow the import of pluripotent stem cell lines produced abroad” (DFG, 2001). The cen-
tral issue of the debate that followed was if research on embryonic stem cells was to be per-
mitted. Linked to that issue was the question whether they could be produced for research or
if they could at least be imported.
The critics of stem cell research argued unanimously that the human embryo had a moral
status and, thus, must not be “produced” only to be used and discarded later. Human life
began with the fusion of egg and sperm cell, thus, research on embryos was not permissible.
“The freedom of research is not without limits”. Herta Däubler-Gmelin says, no embryo
may be sacrificed for vague future visions of cure. (interview with the minister of justice,
SZ, 12 May 2001, p. 8)
The proponents use a diverse array of arguments. One line appeals to economic reasons: to
prevent stem cell research would jeopardize Germany’s position in the globalized economy.
Another strategy is to refer to existing regulations and practice with regard to abortion and
other techniques of reproductive medicine. The main line of argumentation, however, is once
again the appeal to health interests. A possible revolution in medicine is promised however
cautiously. Once stem cell research achieved maturity, individualized therapy of organs would
be feasible.
Because stem cells are flexible, brain, kidney and heart cells could be grown from them
and used for the repair of damaged organs. Maybe no patient would have to die while
being on a waiting list for donor organs. (FAZ, 24 January 2001, p. 11)
4. Discussion
The comparison between the three debates shows a number of both commonalities and dif-
ferences. Biomedical research is news for the media. Media attention to biomedicine has
intensified, and so have the debates over particular aspects of biomedical techniques.15 (This
must be seen in perspective, however. The share of science related articles is relatively small,
c. 5 percent, and that of medicine related ones is even smaller (Kohring, 2005).) Most of the
attention is paid to cloning and to stem cell research, a finding that is supported by the paral-
lel analysis of biomedicine in television news (Ruhrmann and Milde, 2006). The reason lies
most likely in the controversial nature of these two technologies.
The debates all focus on conflicts between new knowledge and institutionalized ethical
values, but nevertheless the foci differ. Not in all cases was the announcement of new knowledge
or a new technology the actual reason for the beginning of the debate. The stem cell debate in
the media was triggered by the DFG announcement about the import of stem cells. Although
the promises of medical applications appear to be fairly concrete, the ethical opposition was
based on an even more concrete violation of the principle of human inviolability backed, in
the German case, by existing legal provisions. This explains why the debate was more intense
than the other two were.
In the case of the HGP, the actual issue of contention was the “patentability of life” that
seemed to arouse opposition, and became an issue in the media because it was Craig Venter rep-
resenting private business who claimed to have completed the deciphering of the code. A fear
connected to this is the vision of the “gene chip” that would violate the solidarity principle and
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the right to self determination. The utopian scenario of a “eugenics from below” is ambivalent.
Promises of an individualized medicine, fine-tuned to the genetic make-up of the patient, are
countered by fears that illness will become biological fate and force the unfortunate ones to jus-
tify their condition.16 The HGP clearly triggers fewer ethical concerns than the two other tech-
nologies so that the medical promises connected with it seem to be more convincing.
The “Dolly” debate is over the future implications of cloning. In this case the utopian
vision of the cloning of humans is quickly turned into a dystopia.17 Arguments in defense of
the technique that point to the potential applications for the cure of inheritable diseases are
rare. The horror of the duplication of humans and the loss of human dignity is (still) greater
than the distant and uncertain promises of the cures through therapeutic, let alone germinal
cloning. It may be speculated that the cloning debate is still in its early stages.
The number and origin of actors participating is quite different from debate to debate. It
reflects not only the interests involved but also, to an extent, the publics that are involved as
well as the scope of their involvement.
In the debate over stem cell research a greater number of scientists and policymakers was
involved while only few representatives from the church and other social organizations could
position themselves. The debate over “Dolly,” on the other hand, is shaped primarily by policy-
makers, and only few scientists took part. The great number of scientists taking part in the stem
cell debate may be responsible for the fact that media reporting in this debate is very even-
handed. One indicator of the state of the debate is statements in the media about the expected
social reactions to the knowledge or technology in question. These speculations point to the
mechanisms by which the opposition will eventually be overcome, and in what ways the values
will change. The “slippery-slope” argument typically accompanies all controversial technolo-
gies and already signifies the possible breakdown of the values that stand in their way. It is the
argument that characterizes an early phase in the embedding of new knowledge and technology
when the utopian/dystopian dichotomy is still the line of conflict. When the debate has moved
to more detailed and concrete issues, the “slippery-slope” rhetoric is no longer appropriate.
Then, questions of regulation become dominant. This does not mean that consensus has already
been reached. In fact, the more pressing the need for regulation is perceived, the more concrete
the arguments are against the research or technology. It is in this phase that the process of value
change actually takes place. This would also agree with the analysis of biomedicine in televi-
sion news where the shift of actors from scientists to policymakers and ethicists as well as a shift
from benefit to more risk-oriented reporting seem to indicate an increasing politicization and a
growing concern about the risks of the new techniques (Ruhrmann and Milde, 2006).
Our initial hypothesis that the social embedding of new knowledge and technologies
would follow the same pattern has proven to be too simple. Of the three debates analyzed here,
only one (“Dolly”) comes close to the pattern we expected. Even there we can only observe
the wide gap between utopian visions and dystopian opposition early on whereas the prospect
of cloning humans does not become accepted and “normalized.” However, the door is left open
to the cloning of embryos for medical purposes. Two reasons are likely to be responsible for
the seemingly divergent patterns. One is the research design itself. The debates we observed as
they appeared in the media analysis were probably at different stages of their development. In
other words, it is necessary to extend the time period considerably if one wants to capture the
entire process of “embedding” of new knowledge as we defined it above. None of the debates,
cloning, stem cell research and even the HGP, can be considered “closed” at this time. As new
applications are developed, discussions about their acceptability will surely flare up again. The
second, obvious reason is the different nature of the technologies and their impact on dominant
values. The HGP has raised much less opposition than stem cell research and cloning, and
opposition to the latter is stronger and more unanimous than against stem cell research. In the
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case of Germany where the debate on and opposition to stem cell research was more intense
than in the UK, this may be explained partly with the “spectre of eugenics” already mentioned
above, and partly with the different legal context (“law to protect embryos”).
However, there is one obvious commonality between all three debates: in all of them the
trail to ultimate realization of the technologies in question is blazed with promises of medical
advances, and these are perceived as the reasons that will ultimately legitimate the breach of
ethical barriers. Thus, further research will have to look at each case in more detail in order
to identify the particular relationship between the new knowledge in question and the values
affected by it. However, we see the advantage and the novelty of our study in the fact that we
have looked comparatively at three different debates over three different types of knowledge.
Such a comprehensive approach appears warranted in order to overcome the well-known lim-
itations of case studies. Notwithstanding their differences, the issue is to not lose sight of the
similarity between the cases: namely, that with the introduction of new biomedical knowledge
into society, general ethical values such as the integrity of human nature are overcome by
more mundane ones such as health and relief of suffering.
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1 The term “new knowledge” implies new scientific knowledge, technical artefacts and techniques. In this context
the term “debate” means “public communications of actors about themes, positions and arguments related to
them as well as communications about other actors” (Gerhards and Lindgens, 1995: 1).
2 The studies of Kohring et al. (1999) and Hampel et al. (1998) show this for all of biotechnology whereas we
deal with biomedicine only.
3 A longitudinal media analysis dealing with gene transfer into human cells for 1970–2001 shows the importance
of health interests (Voss, 2006).
4 Frankfurter Allgemeine Zeitung (FAZ), Süddeutsche Zeitung (SZ), Bild, Westdeutsche Algemeine Zeitung (WAZ),
Die Welt, die tageszeitung (taz), Handelsblatt, Der Spiegel, Focus and Die Zeit.
5 The corpus of Dolly contains all articles with reference to the cloned sheep Dolly. This is different from the arti-
cles that merely contain the keyword “cloning.”
6 We concentrate on two papers—Frankfurter Allgemeine Zeitung (FAZ) and Süddeutsche Zeitung (SZ)—because
of the large amount of articles dealing with stem cell research.
7 Further results of the quantitative content analysis were not included in this paper since we concentrate on the
qualitative reconstruction of the debates.
8 Owing to the limited availability of electronic data banks this curve is based on the data from seven daily and
weekly papers (Frankfurter Allgemeine Zeitung (FAZ), Süddeutsche Zeitung (SZ), die tageszeitung (taz),
Handelsblatt, Der Spiegel, Focus and Die Zeit).
9 The birth of “Dolly” was also an important news item in the American elite press (Nisbet and Lewenstein, 2002:
373). Since then, the media places more emphasis on ethical and controversial aspects of biotechnology.
10 The HGP was omitted because sufficient data on the debate were supplied from a cooperating project. For this
we thank Jürgen Gerhards.
11 The respective corpus comprises articles of all ten newspapers.
12 The respective corpus comprises articles of all ten newspapers.
13 The respective corpus comprises articles of FAZ and SZ only (see note 6).
14 Analyzing articles of Die Zeit and Frankfurter Rundschau Doring (2005) points out that the media coverage of
the HGP is characterized by images of a new biological determinism.
15 A similar media trend for the American press could be identified by Nisbet and Lewenstein (2002) for the area
of biotechnology (including “green” biotechnology).
16 A study of British media discourse shows similar patterns (Smart, 2003).
394 Public Understanding of Science 17 (3) 
17 The restriction of the Dolly media coverage to the question of human cloning could be observed in other national
contexts (e.g. for Australia see Petersen, 2002). Cf. remarks above on studies of cloning.
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